{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:25:12Z","timestamp":1791523512674,"version":"4.3.4"},"reference-count":14,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T00:00:00Z","timestamp":1644624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We report a 50\u2010year\u2010old Caucasian male with a complicated past medical history who developed extensive polymicrobial osteomyelitis, including a carbapenem\u2010resistant <jats:italic>Acinetobacter baumannii<\/jats:italic> (CRAB). In order to streamline therapy, the patient received compassionate use cefiderocol for 6\u00a0weeks which was well tolerated. In addition, the patient's infection was considered cured at end of treatment. Few cases on the use of prolonged cefiderocol for treatment of osteomyelitis due to CRAB have been published. Our patient did not report adverse reactions, nor did he develop laboratory abnormalities which were assessed throughout and at the end of the 6\u2010week course.<\/jats:p>","DOI":"10.1002\/phar.2660","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T20:34:15Z","timestamp":1643056455000},"page":"268-271","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Successful prolonged treatment of a carbapenem\u2010resistant <i>Acinetobacter baumannii<\/i> hip infection with cefiderocol: A case report"],"prefix":"10.1002","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5551-8745","authenticated-orcid":false,"given":"Lucia","family":"Rose","sequence":"first","affiliation":[{"name":"Department of Pharmacy Cooper University Hospital Camden New Jersey USA"},{"name":"Cooper Medical School of Rowan University Camden New Jersey USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Lai","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease Department of Medicine Cooper University Hospital Camden New Jersey USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Byrne","sequence":"additional","affiliation":[{"name":"Cooper Medical School of Rowan University Camden New Jersey USA"},{"name":"Division of Infectious Disease Department of Medicine Cooper University Hospital Camden New Jersey USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,2,12]]},"reference":[{"key":"e_1_2_5_2_1","unstructured":"Centers for Disease Control and Prevention.Biggest threats and data; 2019 AR Threats Report.https:\/\/www.cdc.gov\/drugresistance\/biggest\u2010threats.html. Accessed April 5 2021."},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2012.12.004"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2010.12.016"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1086\/500202"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e318298a541"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01110-18"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ048"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00093-17"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-020-00286-6"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2016.1204911"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30554-1"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30731-3"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa150"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa185"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/phar.2660","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/phar.2660","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/phar.2660","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:24:57Z","timestamp":1761056697000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/phar.2660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,12]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.1002\/phar.2660"],"URL":"https:\/\/doi.org\/10.1002\/phar.2660","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,12]]},"assertion":[{"value":"2021-08-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}